136 related articles for article (PubMed ID: 11152776)
1. Contrast agents for MR imaging of the liver.
Semelka RC; Helmberger TK
Radiology; 2001 Jan; 218(1):27-38. PubMed ID: 11152776
[TBL] [Abstract][Full Text] [Related]
2. Contrast agents used in MR imaging of the liver.
Karabulut N; Elmas N
Diagn Interv Radiol; 2006 Mar; 12(1):22-30. PubMed ID: 16538580
[TBL] [Abstract][Full Text] [Related]
3. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
4. MR imaging in the evaluation of hepatic metastases.
Imam K; Bluemke DA
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):741-56. PubMed ID: 11149677
[TBL] [Abstract][Full Text] [Related]
5. [Liver-specific MR contrast agents: current status and prospects].
Tanimoto A
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Sep; 61(10):525-33. PubMed ID: 11676169
[TBL] [Abstract][Full Text] [Related]
6. MR contrast agents for liver imaging: what, when, how.
Gandhi SN; Brown MA; Wong JG; Aguirre DA; Sirlin CB
Radiographics; 2006; 26(6):1621-36. PubMed ID: 17102040
[TBL] [Abstract][Full Text] [Related]
7. MR imaging of the liver. Contrast agents.
Mahfouz AE; Hamm B
Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
[TBL] [Abstract][Full Text] [Related]
8. Enhanced liver MR: contrast agents and imaging strategy.
Runge VM; Kirsch JE; Wells JW; Awh MH; Bittner DF; Woolfolk CE
Crit Rev Diagn Imaging; 1993; 34(1-2):1-30. PubMed ID: 8216813
[TBL] [Abstract][Full Text] [Related]
9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
10. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement.
Chang SD; Thoeni RF
AJR Am J Roentgenol; 2008 May; 190(5):1318-23. PubMed ID: 18430850
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
12. Liver MRI with contrast enhancement.
Runge VM
Crit Rev Diagn Imaging; 1997 Jun; 38(3):207-30. PubMed ID: 9226107
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
16. Visceral metastases from melanoma: findings on MR imaging.
Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
[TBL] [Abstract][Full Text] [Related]
17. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced magnetic resonance imaging of the abdomen.
Brown ED; Semelka RC
Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
[TBL] [Abstract][Full Text] [Related]
19. Liver lesion conspicuity: T2-weighted breath-hold fast spin-echo MR imaging before and after gadolinium enhancement--initial experience.
Jeong YY; Mitchell DG; Holland GA
Radiology; 2001 May; 219(2):455-60. PubMed ID: 11323472
[TBL] [Abstract][Full Text] [Related]
20. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
